Achilles Therapeutics to join the Northern Alliance Advanced Therapy Treatment Centre consortiumGlobeNewsWire • 10/12/21
Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/10/21
Achilles Therapeutics Enrolls First US Patient in Ongoing Phase I/IIa Study in Advanced Non-small Cell Lung CancerGlobeNewsWire • 07/01/21
Achilles Therapeutics Reports First Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 05/11/21
Achilles Therapeutics to present at the BofA Securities 2021 Virtual Healthcare ConferenceGlobeNewsWire • 05/05/21
Achilles Therapeutics Appoints Julie O'Neill to Board of Directors and Markwin Velders, Ph.D. joins Scientific Advisory BoardGlobeNewsWire • 05/03/21
Achilles Therapeutics Demonstrates cNeT Product Characterization and Post-Infusion Tracking in a Patient Case Study at the American Association for Cancer Research (AACR) 2021 Annual MeetingGlobeNewsWire • 04/10/21
Achilles Therapeutics Announces Closing of $175.5 million Initial Public OfferingGlobeNewsWire • 04/06/21
U.S. IPO Weekly Recap: The IPO Market Slows With 6 IPOs In The Shortened Holiday WeekSeeking Alpha • 04/02/21